Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study

<p>Abstract</p> <p>Background</p> <p>Zambia was the first African country to change national antimalarial treatment policy to artemisinin-based combination therapy – artemether-lumefantrine. An evaluation during the early implementation phase revealed low readiness of h...

Full description

Bibliographic Details
Main Authors: Chanda Pascalina, Hamer Davidson H, Sipilanyambe Nawa, Ndhlovu Mickey, Zurovac Dejan, Simon Jon L, Snow Robert W
Format: Article
Language:English
Published: BMC 2007-03-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/6/1/31
_version_ 1811244536542789632
author Chanda Pascalina
Hamer Davidson H
Sipilanyambe Nawa
Ndhlovu Mickey
Zurovac Dejan
Simon Jon L
Snow Robert W
author_facet Chanda Pascalina
Hamer Davidson H
Sipilanyambe Nawa
Ndhlovu Mickey
Zurovac Dejan
Simon Jon L
Snow Robert W
author_sort Chanda Pascalina
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Zambia was the first African country to change national antimalarial treatment policy to artemisinin-based combination therapy – artemether-lumefantrine. An evaluation during the early implementation phase revealed low readiness of health facilities and health workers to deliver artemether-lumefantrine, and worryingly suboptimal treatment practices. Improvements in the case-management of uncomplicated malaria two years after the initial evaluation and three years after the change of policy in Zambia are reported.</p> <p>Methods</p> <p>Data collected during the health facility surveys undertaken in 2004 and 2006 at all outpatient departments of government and mission facilities in four Zambian districts were analysed. The surveys were cross-sectional, using a range of quality of care assessment methods. The main outcome measures were changes in health facility and health worker readiness to deliver artemether-lumefantrine, and changes in case-management practices for children below five years of age presenting with uncomplicated malaria as defined by national guidelines.</p> <p>Results</p> <p>In 2004, 94 health facilities, 103 health workers and 944 consultations for children with uncomplicated malaria were evaluated. In 2006, 104 facilities, 135 health workers and 1125 consultations were evaluated using the same criteria of selection. Health facility and health worker readiness improved from 2004 to 2006: availability of artemether-lumefantrine from 51% (48/94) to 60% (62/104), presence of artemether-lumefantrine dosage wall charts from 20% (19/94) to 75% (78/104), possession of guidelines from 58% (60/103) to 92% (124/135), and provision of in-service training from 25% (26/103) to 41% (55/135). The proportions of children with uncomplicated malaria treated with artemether-lumefantrine also increased from 2004 to 2006: from 1% (6/527) to 27% (149/552) in children weighing 5 to 9 kg, and from 11% (42/394) to 42% (231/547) in children weighing 10 kg or more. In both weight groups and both years, 22% (441/2020) of children with uncomplicated malaria were not prescribed any antimalarial drug.</p> <p>Conclusion</p> <p>Although significant improvements in malaria case-management have occurred over two years in Zambia, the quality of treatment provided at the point of care is not yet optimal. Strengthening weak health systems and improving the delivery of effective interventions should remain high priority in all countries implementing new treatment policies for malaria.</p>
first_indexed 2024-04-12T14:26:55Z
format Article
id doaj.art-d14af9258de348dd9f6c1aed510c1d7a
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-04-12T14:26:55Z
publishDate 2007-03-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-d14af9258de348dd9f6c1aed510c1d7a2022-12-22T03:29:25ZengBMCMalaria Journal1475-28752007-03-01613110.1186/1475-2875-6-31Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional studyChanda PascalinaHamer Davidson HSipilanyambe NawaNdhlovu MickeyZurovac DejanSimon Jon LSnow Robert W<p>Abstract</p> <p>Background</p> <p>Zambia was the first African country to change national antimalarial treatment policy to artemisinin-based combination therapy – artemether-lumefantrine. An evaluation during the early implementation phase revealed low readiness of health facilities and health workers to deliver artemether-lumefantrine, and worryingly suboptimal treatment practices. Improvements in the case-management of uncomplicated malaria two years after the initial evaluation and three years after the change of policy in Zambia are reported.</p> <p>Methods</p> <p>Data collected during the health facility surveys undertaken in 2004 and 2006 at all outpatient departments of government and mission facilities in four Zambian districts were analysed. The surveys were cross-sectional, using a range of quality of care assessment methods. The main outcome measures were changes in health facility and health worker readiness to deliver artemether-lumefantrine, and changes in case-management practices for children below five years of age presenting with uncomplicated malaria as defined by national guidelines.</p> <p>Results</p> <p>In 2004, 94 health facilities, 103 health workers and 944 consultations for children with uncomplicated malaria were evaluated. In 2006, 104 facilities, 135 health workers and 1125 consultations were evaluated using the same criteria of selection. Health facility and health worker readiness improved from 2004 to 2006: availability of artemether-lumefantrine from 51% (48/94) to 60% (62/104), presence of artemether-lumefantrine dosage wall charts from 20% (19/94) to 75% (78/104), possession of guidelines from 58% (60/103) to 92% (124/135), and provision of in-service training from 25% (26/103) to 41% (55/135). The proportions of children with uncomplicated malaria treated with artemether-lumefantrine also increased from 2004 to 2006: from 1% (6/527) to 27% (149/552) in children weighing 5 to 9 kg, and from 11% (42/394) to 42% (231/547) in children weighing 10 kg or more. In both weight groups and both years, 22% (441/2020) of children with uncomplicated malaria were not prescribed any antimalarial drug.</p> <p>Conclusion</p> <p>Although significant improvements in malaria case-management have occurred over two years in Zambia, the quality of treatment provided at the point of care is not yet optimal. Strengthening weak health systems and improving the delivery of effective interventions should remain high priority in all countries implementing new treatment policies for malaria.</p>http://www.malariajournal.com/content/6/1/31
spellingShingle Chanda Pascalina
Hamer Davidson H
Sipilanyambe Nawa
Ndhlovu Mickey
Zurovac Dejan
Simon Jon L
Snow Robert W
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Malaria Journal
title Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
title_full Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
title_fullStr Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
title_full_unstemmed Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
title_short Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
title_sort paediatric malaria case management with artemether lumefantrine in zambia a repeat cross sectional study
url http://www.malariajournal.com/content/6/1/31
work_keys_str_mv AT chandapascalina paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy
AT hamerdavidsonh paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy
AT sipilanyambenawa paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy
AT ndhlovumickey paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy
AT zurovacdejan paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy
AT simonjonl paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy
AT snowrobertw paediatricmalariacasemanagementwithartemetherlumefantrineinzambiaarepeatcrosssectionalstudy